Future aspects of BMIPP

International Journal of Cardiac Imaging

Volumn 15, Issue 1, 1999, Pages 79-89

  Tamaki, Nagara ^a   Morita, Koichi ^a   Tsukamoto, Eriko ^a   Kawai, Yuko ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Hokko Memorial Clinic   (Japan)

Author keywords

Fatty acids; Radionuclide imaging; Single photon emission tomography (SPECT)

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; TETROFOSMIN TC 99M;

ANGINA PECTORIS; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; EARLY DIAGNOSIS; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART INFARCTION; HEART PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE CHARACTERIZATION; UNSTABLE ANGINA PECTORIS;

EID: 0032788861     PISSN: 01679899     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006109022417     Document Type: Review

References (64)

1. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardail single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995; 22: 361-381.
2. Machulla HJ, Marsmann M, Dutschka K. Biochemical synthesis of a radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 1980; 5: 171-173.
3. Tamaki N, Kawamoto M. The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol 1994; 1: S72-78.
4. Tamaki N, Fujibayashi Y, Magata Y, et al. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT. J Nucl Cardiol 1995; 2: 256-266.
5. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37: 757-761.
6. Morishita S, Kusuoka H, Yamamichi Y, et al. Kinetics of radioiodinated species in subcellular fractions from rat hearts following administration of iodine-123-labelled 15-(piodophenyl)-3-(R,S) methylpentadecanoic acid (123I-BMIPP). Eur J Nucl Med 1996; 23: 383-389.
7. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of 123I-labeled 15-p-iodophenyl-3-(R,S)-methyl-pentadecanoic acid (BMIPP) in perfused rat heart. J Nucl Med 1995; 36: 1043-1050.
8. Hosokawa R, Nohara R, Fujibayashi Y, et al. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 1996; 37: 1836-1840
9. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285.
10. Kobayashi H, Kusakabe K, Momose M, et al. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndrome. J Nucl Med 1998; 39: 1117-1122.
11. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
12. Fujibayashi Y, Yonekura Y, Tamaki N, et al. Myocardial accumulation of BMIPP in relation to ATP concentration. Ann Nucl Med 1993: 7: 15-18.
13. Nohara R, Okuda K, Ogino M, et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37: 1403-1407.
14. Schelbert HR, Henze E, Sochor H, et al. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J 1986; 111: 1055-1064.
15. Takeda K, Saito K, Makino K, et al. iodine-123-BMIPP myocardial washout and cardiac workload during exercise in normal and ischmeic hearts. J Nucl Med 1997; 38: 559-563.
16. Reinhardt CP, Weinstein H, Marcel R, et al. Comparison of iodine-125-BMIPP and thallium-201 in myocardial hypoperfusion. J Nucl Med 1995; 36: 1645-1653.
17. Kawamoto M, Tamaki, N, Yonekura Y, et al. Significance of myocardial uptake of iodine-123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography. J Nucl Cardiol 1994; 1: 522-528.
18. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995; 36: 1974-1980.
19. Sloof GW, Visser FC, Bax JJ, et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med 1998; 39: 255-260.
20. Miller DD, Gill JB, Livni E, et al. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988; 63: 681-693.
21. Nishimura T, Sago M, Kihara K, et al. Fatty acid myocardial imaging using 123I-β-methyl-iodophenyl pentadecanoic aicd (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989; 15: 341-345.
22. Weiss ES, Hoffman EJ, Phelps ME, Welch MJ, Henry PD, Ter-Pogossian MM, Sobel BE. External detection and visualization of myocardial ischemia with C-11 substrates in vivo and in vitro. Circ Res 1976; 39: 24-32.
23. Hosokawa R, Nohara R, Fujibayashi Y, et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clincial SPECT. J Nucl Med 1997; 38: 1857-1863.
24. Kudoh T, Tamaki N, Magata Y, et al. Metablism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med 1997; 38: 548-553.
25. Kurata C, Wakabayashi Y, Shouda S, et al. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP. J Nucl Med 1997; 38: 1079-1084.
26. Hwang E, Yamashita A, Takemori H, et al. Absent myocardial I-123 BMIPP uptake in a family. Annals Nucl Med 1996; 10: 445-448.
27. Tanaka T, Kawamura K. Isolation of myocardial membrane long-chain fatty acid-binding protein: homology with a rat long-chain fatty acids. J Mol Cell Cardiol 1995; 27: 1613-1622.
28. Kurata C, Kobayashi A, Yamazaki N, et al. Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathy hamsters. J Nucl Med 1989; 30: 80-87.
29. Nakai K, Ahmad M, Nakaki M, et al. Serial course of the left ventricular function, perfusion and radioiodinated fatty acid cardiomyopathic hamster. J Nucl Med 1993; 34: 1309-1315.
30. Vyska M, Machulla H, Stremmel W, et al. Regional myocardial free fatty acid extraction in normal and ischmeic myocardium. Circulation 1988: 78: 1218-1233.
31. Takeishi Y, Sukekawa H, Saito H, et al. Impaired myocardial fatty acid metabolism detected by 123I-BMIPP in patients with unstable angina pectoris: comparison with perfusion imaging by 99mTc-sestamibi. Ann Nucl Med 1995; 9: 125-130.
32. Takeishi Y, Sukekawa H, Saito H, et al. Clinical significance of decreased myocardial uptake of 123I-BMIPP in patients with stable effort angina pectoris. Nucl Med Commun 1995; 16: 1002-1008.
33. Nakajima K, Schimizu K, Taki J, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995; 36: 1934-1940.
34. Tateno M, Tamaki N, Kudoh T, et al. Assessment of fatty acid uptake in patients with ischmeic heart disease without myocardial infarction. J Nucl Med 1996; 37: 1981-1985.
35. Takeishi Y, Fujiwara S, Atsumi H, et al. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional therapy. J Nucl Med 1997; 38: 1407-1411.
36. Yoshida S, Ito M, Mitsunami K, Kinoshita M. Improved myocardial fatty acid metabolism after coronary angioplasty in chronic coronary artery disease. J Nucl Med 1998; 39: 933-938.
37. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ikekubo K, Kato H. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocadial infarction: assessment with emission tomography using an ioclonated branched fatty acid. J Nucl Med 1992, 33: 659-667.
38. DeGeeter F, Franken P, Knapp FF Jr, et al. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of Tc-99m sestamibi and iodine-123-beta-methyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994; 21: 283-291.
39. Franken P, DeGeeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765
40. Matsunari I, Saga T, Taki J, et al. Improved myocardial fatty acid utilization after percutaneous transmural coronary angioplasty. J Nucl Med 1995; 36: 1605-1607.
41. Tamaki N, Tadamura E, Kudoh T, et al. Recent advances in nuclear cardiology in the study of coronary artery disease. Ann Nucl Med 1997; 11: 55-66.
42. Taki J, Nakajima K, Matsunari I, et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischemic but viable myocardium. Eur J Nucl Med 1995, 22: 1385-1392.
43. Taki J, Nakajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.
44. Tsubokura A, Lee JD, Shimizu H, et al. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium. J Nucl Med 1997; 38: 1835-1837.
45. Kawai Y, Tsukamoto E, Nozaki Y, et al. Use of 1231-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med 1998; 25: 1390-1395.
46. Furutani Y, Shiigi T, Nakamura Y, et al. Quantification of area at risk in acute myocardial infarction by tomographic imaging. J Nucl Med 1997; 38: 1875-1882.
47. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium. Ann Nucl Med 1994; 8: 47-54.
48. Franken PR, Dendale P, DeGeeter F, et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
49. 201Tl SPECT images. Eur J Nucl Med 1996: 23: 917-923.
50. Hashimoto A, Nakata T, Tsuchihashi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
51. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996; 23: 272-279.
52. Grover-McKay M, Schwaiger M, Krivokapitch J, et al. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13: 317-324.
53. Tadamura E, Tamaki N, Matsumori A, et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 1996; 37: 572-577.
54. Kuruta C, Taniguchi T, Aoshima S, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13.
55. Takeishi Y, Chiba J, Abe S, et al. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992; 19: 775- 782.
56. Ohtsuki K, Sugihara H, Umamoto I, et al. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (123I-BMIPP). Nucl Med Commun 1994; 14: 441-447.
57. Taki J, Nakajima K, Bunko H, et al. 123I-labelled BMIPP fatty acid myocardial scintigraphy in patients with hypertrophic cardiomyopathy. Nucl Med Commun 1994; 14: 181-188.
58. Tadamura E, Kudoh T, Tamaki N, et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998; 39: 390-396.
59. Nishimura T, Nagata S, Uehara T, et al. Prognosis of hypertrophic cardiomyopathy; assessment by 123I-BMIPP myocardial single photon emission computed tomography. Ann Nucl Med 1996; 10: 71-78.
60. Mochizuki T, Tsukamoto E, Ono T, Itoh K, Kanegae K, et al: Sequential change of BMIPP uptake with age in spontaneously hypertensive rat model. Ann Nucl Med 1997; 11: 299-306.
61. Ono T, Tsukamoto E, Mochizuki T, et al. Regression of left ventricular hypertrophy improves fatty acid metabolism in hypertensive rats (Abstract). J Nucl Med 1997; 38: 42.
62. Hashimoto Y, Yamabe H, Yokoyama M, et al. Myocardial defect detected by 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy. Ann Nucl Med 1996; 10: 225-230.
63. Kim Y, Goto H, Kobayashi K, et al. Detection of imparied fatty acid metabolism in right ventricular hypertrophy: assessment by 123I β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography. Ann Nucl Med 1997:;11: 207-212.
64. Kondo C, Nakazawa M, Kusakabe K, et al. Myocardial dysfunction and depressed fatty acid metabolism in patients with cyanotic congenital heart disease. J Nucl Cardiol 1996; 3: 30-36.